The effect of omega-3 supplementation on pregnancy outcomes by smoking status
- PMID: 28549983
- PMCID: PMC5614814
- DOI: 10.1016/j.ajog.2017.05.033
The effect of omega-3 supplementation on pregnancy outcomes by smoking status
Abstract
Background: Smoking during pregnancy is associated with adverse maternal and neonatal outcomes such as preterm delivery, intrauterine growth restriction, stillbirth, and low birth weight. Because smoking causes oxidative stress, some have suggested using antioxidants to counteract the effects of oxidative stress. Smokers have lower serum levels of omega-3 fatty acids, an important antioxidant, and thus, investigating whether omega-3 supplementation in smokers reduces adverse maternal and neonatal outcomes represents an important area of research.
Objective: To investigate whether the antioxidant effect of omega-3 fatty acid supplementation on the incidence of adverse pregnancy outcomes differs between smokers and nonsmokers.
Study design: Secondary analysis of a multicenter randomized controlled trial of omega-3 supplementation for preterm delivery prevention in women with a singleton pregnancy and a history of a previous singleton spontaneous preterm delivery. Subjects were randomized to begin omega-3 or placebo before 22 weeks, which was continued until delivery. All women received 17 alpha-hydroxyprogesterone caproate intramuscularly weekly beginning between 16 and 20 weeks of gestation and continued until 36 weeks of gestation or delivery, whichever occurred first. The primary outcome was spontaneous preterm delivery. Secondary outcomes were indicated preterm delivery, any preterm delivery (spontaneous and indicated), pregnancy-associated hypertension (gestational hypertension and preeclampsia), a neonatal composite (retinopathy of prematurity, intraventricular hemorrhage grade III or IV, patent ductus arteriosus, necrotizing enterocolitis, sepsis, respiratory morbidity, or perinatal death), low birth weight (<2500 g), small for gestational age (less than the 10th percentile), and neonatal intensive care unit or intermediate nursery admission. The study population was stratified into smokers and nonsmokers, and the incidence of each outcome was compared by omega-3 supplementation versus placebo in each subgroup. Zelen tests were performed to test for homogeneity of effect in smokers and nonsmokers.
Results: Of 851 subjects included in the analysis, 136 (16%) smoked. Baseline characteristics between omega-3 and placebo groups did not differ in smokers or nonsmokers. Omega-3 supplementation was associated with a lower risk of spontaneous preterm delivery in smokers (relative risk, 0.56, 95% confidence interval, 0.36-0.87) but not in nonsmokers (relative risk 1.04, 95% confidence interval 0.84-1.29); P value for interaction = 0.013. Low birth weight was also less frequent in smokers receiving omega-3 supplementation (relative risk 0.57, 95% confidence interval 0.36-0.90) compared with nonsmokers (relative risk 0.93, 95% confidence interval 0.71-1.24); P value for interaction = 0.047. The effect on other secondary outcomes did not differ significantly between smokers and nonsmokers.
Conclusion: Omega-3 supplementation in smokers may have a protective effect against recurrent spontaneous preterm delivery and low birth weight.
Keywords: low birth weight; omega-3 supplementation; preterm birth; preterm delivery; smoking; spontaneous preterm delivery; tobacco abuse.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
CONFLICTS OF INTEREST: The authors report no conflicts of interest.
Figures
Comment in
-
Prevention of adverse pulmonary, neurological, and ocular perinatal outcomes by supplementing omega-3 fatty acids during pregnancy.Am J Obstet Gynecol. 2018 Jul;219(1):120-121. doi: 10.1016/j.ajog.2018.03.019. Epub 2018 Mar 28. Am J Obstet Gynecol. 2018. PMID: 29601796 No abstract available.
-
Reply.Am J Obstet Gynecol. 2018 Jul;219(1):121. doi: 10.1016/j.ajog.2018.03.020. Epub 2018 Mar 28. Am J Obstet Gynecol. 2018. PMID: 29601798 No abstract available.
Similar articles
-
Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.Am J Obstet Gynecol. 2017 Sep;217(3):371.e1-371.e7. doi: 10.1016/j.ajog.2017.05.022. Epub 2017 May 17. Am J Obstet Gynecol. 2017. PMID: 28526452
-
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.Am J Perinatol. 2020 Jan;37(2):127-136. doi: 10.1055/s-0039-3400227. Epub 2019 Oct 25. Am J Perinatol. 2020. PMID: 31652479 Clinical Trial.
-
Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.Am J Obstet Gynecol. 2016 Nov;215(5):622.e1-622.e8. doi: 10.1016/j.ajog.2016.07.013. Epub 2016 Jul 11. Am J Obstet Gynecol. 2016. PMID: 27418444 Free PMC article. Clinical Trial.
-
Omega-3 supplementation to prevent recurrent preterm birth: a systematic review and metaanalysis of randomized controlled trials.Am J Obstet Gynecol. 2015 Aug;213(2):135-40. doi: 10.1016/j.ajog.2015.03.013. Epub 2015 Mar 7. Am J Obstet Gynecol. 2015. PMID: 25757636 Review.
-
Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis.Obstet Gynecol. 2015 Mar;125(3):663-672. doi: 10.1097/AOG.0000000000000668. Obstet Gynecol. 2015. PMID: 25730231 Review.
Cited by
-
Effects of n-3 polyunsaturated fatty acid supplementation on pregnancy outcomes: a systematic review and meta-analysis.Arch Med Sci. 2021 Aug 26;18(4):890-899. doi: 10.5114/aoms/141577. eCollection 2022. Arch Med Sci. 2021. PMID: 35832715 Free PMC article. Review.
-
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers.Trials. 2021 Dec 14;22(1):922. doi: 10.1186/s13063-021-05865-7. Trials. 2021. PMID: 34906201 Free PMC article.
-
Omega-3 fatty acid addition during pregnancy.Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD003402. doi: 10.1002/14651858.CD003402.pub3. Cochrane Database Syst Rev. 2018. PMID: 30480773 Free PMC article.
-
Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say "No," but Is It the Final Word?Nutrients. 2017 Dec 15;9(12):1364. doi: 10.3390/nu9121364. Nutrients. 2017. PMID: 29244779 Free PMC article. Review.
-
Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy.Am J Obstet Gynecol. 2018 Jan;218(1):136.e1-136.e10. doi: 10.1016/j.ajog.2017.10.040. Epub 2017 Nov 1. Am J Obstet Gynecol. 2018. PMID: 29100869 Free PMC article.
References
-
- Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol. 1957;73:807–15. - PubMed
-
- Mainous AG, 3rd, Hueston WJ. The effect of smoking cessation during pregnancy on preterm delivery and low birthweight. J Fam Pract. 1994;38:262–6. - PubMed
-
- Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998;179:1051–5. - PubMed
-
- Kyrklund-Blomberg NB, Granath F, Cnattingius S. Maternal smoking and causes of very preterm birth. Acta Obstet Gynecol Scand. 2005;84:572–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical